Impact of β-adrenergic blockade on efficacy of immunotherapy in patients with metastatic clear cell renal cell carcinoma

被引:0
|
作者
Semaan, Karl
Eid, Marc
Saad, Eddy
Issa, Wadih
Saliby, Renee Maria
Paul, Morgan
Zhong, Caiwei
Gunenc, Damla
Phillips, Noa
Nawfal, Rashad
Machaalani, Marc
Chehade, Razane El Hajj
Yekeduz, Emre
Labaki, Chris
El Zarif, Talal
Baca, Sylvan C.
Xie, Wanling
McGregor, Bradley Alexander
Zhang, Tian
Choueiri, Toni K.
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Univ Texas Southwestern, Dept Internal Med, Div Hematol & Oncol, Dallas, TX USA
[3] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA
[4] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA
[5] Dana Farber Canc Inst, Dept Data Sci, Boston, MA 02115 USA
[6] Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e16529
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Treating metastatic clear-cell renal cell carcinoma: beyond immunotherapy
    Gianluca Perego
    Paolo Barzaghi
    Ivano Vavassori
    Fausto Petrelli
    Medical Oncology, 2020, 37
  • [2] Treating metastatic clear-cell renal cell carcinoma: beyond immunotherapy
    Perego, Gianluca
    Barzaghi, Paolo
    Vavassori, Ivano
    Petrelli, Fausto
    MEDICAL ONCOLOGY, 2020, 37 (09)
  • [3] Immunotherapy: A new standard in the treatment of metastatic clear cell renal cell carcinoma
    Popovic, Maja
    Matovina-Brko, Gorana
    Jovic, Masa
    Popovic, Lazar S.
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2022, 13 (01): : 28 - 38
  • [4] Abnormal coagulation as prognostic factor to impact on efficacy of immunotherapy in metastatic renal cell carcinoma patients
    Tsimafeyeu, I.
    Madzhuga, A.
    Demidov, L.
    Somonova, O.
    Yelizarova, A.
    Kharkevich, G.
    EJC SUPPLEMENTS, 2007, 5 (04): : 101 - 102
  • [5] Efficacy and safety of dupilumab in a patient with metastatic clear cell renal cell carcinoma
    Ferreira, Cesar
    Freitas, Egidio
    Torres, Tiago
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2024, 52 (11)
  • [6] Clinical impact of targeted therapies in patients with metastatic clear-cell renal cell carcinoma
    Hugues, Marion
    Nerich, V
    Nai, T.
    Paillard, M. J.
    Borowski, L.
    Stein, U.
    Hon, Nguyen Tan T.
    Montcuquet, P.
    Maurina, T.
    Mouillet, G.
    Kleinclauss, F.
    Pivot, X.
    Thiery-Vuillemin, A.
    Limat, S.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 271 - 271
  • [7] Clinical impact of targeted therapies in patients with metastatic clear-cell renal cell carcinoma
    Nerich, Virginie
    Hugues, Marion
    Paillard, Marie Justine
    Borowski, Laetitia
    Nai, Thierry
    Stein, Ulrich
    Hon, Thierry Nguyen Tan
    Montcuquet, Philippe
    Maurina, Tristan
    Mouillet, Guillaume
    Kleinclauss, Francois
    Pivot, Xavier
    Limat, Samuel
    Thiery-Vuillemin, Antoine
    ONCOTARGETS AND THERAPY, 2014, 7 : 365 - 374
  • [8] Relationship of Pathological Factors To Efficacy of Sorafenib Treatment in Patients With Metastatic Clear Cell Renal Cell Carcinoma
    Tsuzuki, Toyonori
    Araki, Hidemori
    Kimura, Tohru
    Tanaka, Kuniaki
    Yamada, Shin
    Sassa, Naoto
    Yoshino, Yasushi
    Hattori, Ryohei
    Gotoh, Momokam
    MODERN PATHOLOGY, 2015, 28 : 263A - 264A
  • [9] Relationship of Pathologic Factors to Efficacy of Sorafenib Treatment in Patients With Metastatic Clear Cell Renal Cell Carcinoma
    Araki, Hidemori
    Tsuzuki, Toyonori
    Kimura, Tohru
    Tanaka, Kuniaki
    Yamada, Shin
    Sassa, Naoto
    Yoshino, Yasushi
    Hattori, Ryohei
    Gotoh, Momokazu
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 143 (04) : 492 - 499
  • [10] Relationship of Pathological Factors To Efficacy of Sorafenib Treatment in Patients With Metastatic Clear Cell Renal Cell Carcinoma
    Tsuzuki, Toyonori
    Araki, Hidemori
    Kimura, Tohru
    Tanaka, Kuniaki
    Yamada, Shin
    Sassa, Naoto
    Yoshino, Yasushi
    Hattori, Ryohei
    Gotoh, Momokazu
    LABORATORY INVESTIGATION, 2015, 95 : 263A - 264A